X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (285167) 285167
Newspaper Article (55345) 55345
Newsletter (22827) 22827
Web Resource (4611) 4611
Magazine Article (1684) 1684
Book Chapter (1422) 1422
Dissertation (689) 689
Trade Publication Article (526) 526
Book / eBook (332) 332
Publication (281) 281
Conference Proceeding (223) 223
Transcript (155) 155
Reference (123) 123
Book Review (112) 112
Government Document (69) 69
Streaming Video (44) 44
Journal / eJournal (33) 33
Report (29) 29
Paper (19) 19
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (192302) 192302
lymphomas (126286) 126286
male (96671) 96671
female (92290) 92290
oncology (68686) 68686
middle aged (63625) 63625
cancer (61420) 61420
adult (60964) 60964
lymphoma (52340) 52340
hematology (49246) 49246
aged (49024) 49024
animals (37581) 37581
leukemia (33355) 33355
research (33207) 33207
chemotherapy (32210) 32210
adolescent (30998) 30998
child (29080) 29080
prognosis (23772) 23772
mice (23071) 23071
non-hodgkin's lymphomas (22333) 22333
care and treatment (21815) 21815
tumors (18312) 18312
child, preschool (18050) 18050
antineoplastic combined chemotherapy protocols - therapeutic use (17355) 17355
pathology (16469) 16469
expression (15961) 15961
aged, 80 and over (15879) 15879
treatment outcome (15830) 15830
apoptosis (15605) 15605
medical research (15549) 15549
diagnosis (14850) 14850
non-hodgkins-lymphoma (14270) 14270
lymphoma - pathology (14004) 14004
patients (13992) 13992
diagnosis, differential (13835) 13835
retrospective studies (13793) 13793
immunology (13761) 13761
analysis (13503) 13503
health aspects (13209) 13209
risk factors (13050) 13050
disease (12971) 12971
t cells (12580) 12580
clinical trials (12365) 12365
therapy (12210) 12210
immunohistochemistry (11904) 11904
cancer therapies (11754) 11754
transplantation (11486) 11486
b-cell lymphoma (11292) 11292
genetic aspects (11206) 11206
lymphocytes (10801) 10801
biopsy (10676) 10676
infant (10484) 10484
rituximab (10449) 10449
proteins (10226) 10226
hemic and lymphatic diseases (10211) 10211
pediatrics (10042) 10042
lymphoma, non-hodgkin - pathology (9907) 9907
gene expression (9653) 9653
antineoplastic agents - therapeutic use (9516) 9516
survival (9481) 9481
young adult (9384) 9384
cell biology (9266) 9266
children (9264) 9264
mutation (9229) 9229
pharmaceutical industry (9208) 9208
cell line, tumor (8961) 8961
medicine, general & internal (8759) 8759
immunotherapy (8700) 8700
medicine & public health (8595) 8595
stem cells (8506) 8506
surgery (8366) 8366
follow-up studies (8259) 8259
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8189) 8189
drug therapy (8164) 8164
cell line (7939) 7939
combined modality therapy (7908) 7908
tumor cells, cultured (7843) 7843
biochemistry & molecular biology (7786) 7786
flow cytometry (7785) 7785
neoplasm staging (7731) 7731
medicine (7627) 7627
time factors (7615) 7615
lymphoma - diagnosis (7462) 7462
oncology, experimental (7442) 7442
lymphoma, large b-cell, diffuse - pathology (7401) 7401
bone marrow (7327) 7327
lymphoma, non-hodgkin - drug therapy (7283) 7283
medicine, experimental (7241) 7241
lymphoma - immunology (7200) 7200
risk (7105) 7105
multiple myeloma (7087) 7087
tomography, x-ray computed (7013) 7013
polymerase chain reaction (6885) 6885
studies (6884) 6884
medicine, research & experimental (6813) 6813
radiology, nuclear medicine & medical imaging (6778) 6778
precursor cell lymphoblastic leukemia-lymphoma - genetics (6660) 6660
acute lymphoblastic-leukemia (6652) 6652
survival rate (6598) 6598
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (198) 198
Online Resources - Online (122) 122
Collection Dvlpm't (Acquisitions) - Vendor file (19) 19
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Gerstein Science - Periodical Stacks (5) 5
Scarborough Hospital - Hospital Department (5) 5
Scarborough Hospital - Online (5) 5
Robarts - Stacks (4) 4
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Bindery (2) 2
Scarborough Hospital - General (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University Archives - Archives (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (341135) 341135
French (7181) 7181
Japanese (6892) 6892
German (6480) 6480
Chinese (4047) 4047
Spanish (3959) 3959
Russian (2992) 2992
Italian (2233) 2233
Polish (1458) 1458
Korean (1070) 1070
Portuguese (1022) 1022
Czech (519) 519
Hungarian (397) 397
Turkish (305) 305
Dutch (293) 293
Danish (187) 187
Romanian (181) 181
Norwegian (145) 145
Croatian (125) 125
Swedish (102) 102
Hebrew (101) 101
Serbian (100) 100
Finnish (86) 86
Bulgarian (77) 77
Slovak (68) 68
Persian (42) 42
Ukrainian (30) 30
Arabic (15) 15
Greek (14) 14
Slovenian (13) 13
Lithuanian (10) 10
Bosnian (9) 9
Afrikaans (6) 6
Latvian (4) 4
Catalan (3) 3
Indonesian (3) 3
Urdu (3) 3
Hindi (2) 2
Manx (2) 2
Belarusian (1) 1
Breton (1) 1
Estonian (1) 1
Galician (1) 1
Latin (1) 1
Thai (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 2nd ed., ISBN 9780781791168, xiv, 597
Book
2004, ISBN 9780781735261, xix, 856
Book
1997, 2nd ed., ISBN 0340557931, xvi, 1149
Book
1990, ISBN 0683058959, xvi, 430
Book
The American journal of surgical pathology, ISSN 0147-5185, 2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | TRANSFORMATION | SURGERY | TRANSLOCATION | T(14/18) | T(14-18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | ACUTE LYMPHOBLASTIC-LEUKEMIA | EXPRESSION | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 1989
Journal
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | MULTIPLE-MYELOMA | chronic lymphocytic leukemia (CLL) | acute lymphoblastic leukemia (ALL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SOMATIC MUTATIONS | TRANSCRIPTIONAL FINGERPRINTS | diffuse large B-cell lymphoma (DLBCL) | burkitt lymphoma (BL) | BURKITT-LYMPHOMA | gene regulation | circular RNA | POOR-PROGNOSIS | PROFILING REVEALS | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM) | EXPRESSION | PROMOTES | LNCRNA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites
Journal Article
Journal Article
American journal of hematology, ISSN 0361-8609, 2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
Investigational new drugs, ISSN 1573-0646, 2018, Volume 37, Issue 2, pp. 297 - 306
Purpose This first-in-human study evaluated SGN-CD70A, an antibody-drug conjugate (ADC) directed against the integral plasma membrane protein CD70 and linked... 
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Diffuse | large B cell | ONCOLOGY | lymphoma (DLBCL) | PLUS RITUXIMAB | PHARMACOLOGY & PHARMACY | OUTCOMES | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism | Lymphoma, B-Cell - drug therapy | CD27 Ligand - immunology | Lymphoma, B-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Recurrence, Local - metabolism | Antibodies, Monoclonal - pharmacokinetics | Lymphoma, Mantle-Cell - drug therapy | Maximum Tolerated Dose | Lymphoma, Mantle-Cell - immunology | Lymphoma, B-Cell - pathology | Benzodiazepines - chemistry | Pyrroles - chemistry | Aged | Drug Resistance, Neoplasm - drug effects | Thrombocytopenia | Anemia | Fatigue | Nausea | Exposure | Lymphoma | Patients | Anticancer properties | Membrane proteins | Proteins | Studies | Lymphocytes B | Mantle cell lymphoma | Antitumor activity | Remission | Lymphomas | Dimers | Mantle | Drug dosages | B-cell lymphoma | Phase I Studies
Journal Article